Simplex Trading’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$904K Sell
2,700
-3,200
-54% -$1.01M ﹤0.01% 2898
2026
Q1
$1.9M Buy
+5,900
New +$1.83M ﹤0.01% 1858
2025
Q4
Sell
-5,100
Closed -$270K 9749
2025
Q3
$270K Buy
5,100
+1,300
+34% +$63K ﹤0.01% 4604
2025
Q2
$159K Sell
3,800
-6,900
-64% -$263K ﹤0.01% 4750
2025
Q1
$405K Sell
10,700
-10,600
-50% -$662K ﹤0.01% 3621
2024
Q4
$1.64M Sell
21,300
-1,100
-5% -$79.6K ﹤0.01% 2375
2024
Q3
$1.29M Buy
22,400
+20,800
+1,300% +$1.12M ﹤0.01% 2686
2024
Q2
$66K Buy
1,600
+100
+7% +$4.73K ﹤0.01% 5795
2024
Q1
$91K Buy
+1,500
New +$67.3K ﹤0.01% 5685
2023
Q4
Sell
-1,533
Closed -$39K 9593
2023
Q3
$39K Buy
1,533
+580
+61% +$11K ﹤0.01% 6033
2023
Q2
$16K Buy
953
+433
+83% +$6.63K ﹤0.01% 6989
2023
Q1
$6K Buy
+520
New +$21.9K ﹤0.01% 7928
2022
Q4
Sell
-440
Closed -$14K 10153
2022
Q3
$14K Sell
440
-387
-47% -$19.3K ﹤0.01% 7921
2022
Q2
$30K Buy
827
+574
+227% +$61.3K ﹤0.01% 7159
2022
Q1
$38K Buy
253
+246
+3,514% +$50.5K ﹤0.01% 7507
2021
Q4
$1K Sell
7
-33
-83% -$9.68K ﹤0.01% 10230
2021
Q3
$11K Hold
40
﹤0.01% 8879
2021
Q2
$10K Buy
+40
New +$14.3K ﹤0.01% 9104

Other funds holding PRAX

Simplex Trading's PRAX Position: Q2 2026 in Review

Simplex Trading sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 1,660 shares — an estimated $525K sold.

Simplex Trading first reported a position in PRAX in Q4 2021 and held it in 13 quarters. The position peaked at $1.3M in Q4 2024. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Simplex Trading reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 1,660 Praxis Precision Medicines shares in Q2 2026, an estimated $525K.
  • Simplex Trading first reported a position in Praxis Precision Medicines in Q4 2021 and held it in 13 quarters.
  • Simplex Trading's Praxis Precision Medicines position peaked at $1.3M in Q4 2024.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.